<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>HiF-DTA: Hierarchical Feature Learning Network for Drug-Target Affinity Prediction - Health AI Hub</title>
    <meta name="description" content="HiF-DTA is a novel hierarchical deep learning network designed to improve Drug-Target Affinity (DTA) prediction by addressing limitations in existing sequence-b">
    <link rel="icon" type="image/svg+xml" href="../favicon.svg">
    <link rel="icon" type="image/png" sizes="32x32" href="../favicon-32x32.png">
    <link rel="icon" type="image/png" sizes="16x16" href="../favicon-16x16.png">
    <link rel="stylesheet" href="../styles.css">
</head>
<body>
    <header>
        <div class="container">
            <div class="breadcrumb">
                <a href="../index.html">‚Üê Back to all papers</a>
                <a href="../index.html" class="home-btn">üè† Home</a>
            </div>
        </div>
    </header>

    <main class="container paper-detail">
        <article>
            <h1>HiF-DTA: Hierarchical Feature Learning Network for Drug-Target Affinity Prediction</h1>

            <div class="paper-metadata">
                <div class="meta-row">
                    <strong>arXiv ID:</strong> <a href="http://arxiv.org/abs/2510.27281v1" target="_blank">2510.27281v1</a>
                </div>
                <div class="meta-row">
                    <strong>Published:</strong> 2025-10-31
                </div>
                <div class="meta-row">
                    <strong>Authors:</strong> Minghui Li, Yuanhang Wang, Peijin Guo, Wei Wan, Shengshan Hu, Shengqing Hu
                </div>
                <div class="meta-row">
                    <strong>Categories:</strong> cs.LG, cs.AI
                </div>
                <div class="meta-row">
                    <strong>Relevance Score:</strong> 1.00 / 1.00
                </div>
            </div>

            <div class="action-buttons">
                <a href="http://arxiv.org/abs/2510.27281v1" target="_blank" class="btn btn-primary">View on arXiv</a>
                <a href="http://arxiv.org/pdf/2510.27281v1" target="_blank" class="btn btn-primary">Download PDF</a>
            </div>

            <section class="paper-section">
                <h2>Summary</h2>
                <p class="summary-text">HiF-DTA is a novel hierarchical deep learning network designed to improve Drug-Target Affinity (DTA) prediction by addressing limitations in existing sequence-based methods. It achieves superior performance by simultaneously extracting global sequence semantic and local topological features from drugs and proteins, and by modeling drugs with multi-scale representations (atomic, substructural, molecular) fused via bilinear attention. This approach significantly outperforms state-of-the-art baselines, confirming the importance of its global-local extraction and multi-scale fusion components.</p>
            </section>

            <section class="paper-section">
                <h2>Medical Relevance</h2>
                <p>Accurate and efficient Drug-Target Affinity (DTA) prediction is critical for accelerating early screening in drug discovery, reducing the enormous costs and time associated with experimental validation. This ultimately speeds up the development and availability of new therapeutic drugs for patients.</p>
            </section>

            
            <section class="paper-section">
                <h2>AI Health Application</h2>
                <p>This research develops an AI model (HiF-DTA, a hierarchical deep learning network) to predict the binding affinity between drug molecules and target proteins. This application of AI to health aims to significantly accelerate the early stages of drug discovery, reduce the high costs associated with experimental screening, and improve the efficiency of identifying potential drug candidates for various diseases.</p>
            </section>
            

            <section class="paper-section">
                <h2>Key Points</h2>
                <ul class="key-points">
                    
                    <li>**Problem Addressed**: Existing sequence-based DTA methods overlook simultaneous modeling of global sequence semantics and local topological structural features, and represent drugs as flat sequences without multi-scale (atomic, substructural, molecular) information.</li>
                    
                    <li>**HiF-DTA Architecture**: Proposes a hierarchical network with a dual-pathway strategy to extract both global sequence semantic and local topological features from drug and protein sequences.</li>
                    
                    <li>**Multi-scale Drug Representation**: Uniquely models drugs at multiple scales (atomic-level, substructural-level, molecular-level) to learn comprehensive representations.</li>
                    
                    <li>**Feature Fusion Mechanism**: Incorporates a multi-scale bilinear attention module to effectively fuse the diverse learned multi-scale drug representations.</li>
                    
                    <li>**State-of-the-Art Performance**: HiF-DTA significantly outperforms existing state-of-the-art baseline models on well-established DTA benchmark datasets, including Davis, KIBA, and Metz.</li>
                    
                    <li>**Ablation Study Validation**: Ablation experiments confirm the critical importance and contribution of both the global-local feature extraction strategy and the multi-scale feature fusion components to HiF-DTA's superior predictive power.</li>
                    
                    <li>**Objective**: The overall goal is to reduce experimental costs and accelerate early screening in computational drug discovery, thereby streamlining the drug development process.</li>
                    
                </ul>
            </section>

            <div class="two-column">
                <section class="paper-section">
                    <h2>Methodology</h2>
                    <p>HiF-DTA is a hierarchical deep learning network that employs a dual-pathway strategy to extract both global sequence semantic and local topological features from drug and protein sequences. For drugs, it models multi-scale features (atomic, substructural, molecular levels). These learned representations are then fused using a multi-scale bilinear attention module to predict Drug-Target Affinity.</p>
                </section>

                <section class="paper-section">
                    <h2>Key Findings</h2>
                    <p>HiF-DTA achieves superior performance compared to state-of-the-art baselines on Davis, KIBA, and Metz datasets. Ablation studies confirm that both the global-local feature extraction and the multi-scale feature fusion mechanisms are essential components contributing to its enhanced predictive accuracy for Drug-Target Affinity.</p>
                </section>
            </div>

            <section class="paper-section">
                <h2>Clinical Impact</h2>
                <p>By providing a more accurate and efficient computational method for predicting DTA, HiF-DTA can significantly reduce the time, resources, and costs involved in the early stages of drug discovery and development. This acceleration can lead to quicker identification of promising drug candidates, faster market entry for new therapies, and ultimately, more accessible and effective treatments for various diseases, benefiting patients worldwide.</p>
            </section>

            
            <section class="paper-section">
                <h2>Limitations</h2>
                <p>The abstract does not explicitly state any limitations or caveats of the HiF-DTA model itself. It primarily focuses on the limitations of existing methods that HiF-DTA aims to overcome.</p>
            </section>
            

            
            <section class="paper-section">
                <h2>Future Directions</h2>
                <p>The abstract does not explicitly mention any specific future research directions for HiF-DTA.</p>
            </section>
            

            <section class="paper-section">
                <h2>Medical Domains</h2>
                <div class="tags">
                    
                    <span class="tag">Pharmacology</span>
                    
                    <span class="tag">Drug Discovery</span>
                    
                    <span class="tag">Pharmaceutical Research</span>
                    
                    <span class="tag">Bioinformatics</span>
                    
                    <span class="tag">Medicinal Chemistry</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Keywords</h2>
                <div class="tags">
                    
                    <span class="tag tag-keyword">Drug-Target Affinity (DTA)</span>
                    
                    <span class="tag tag-keyword">Deep Learning</span>
                    
                    <span class="tag tag-keyword">Hierarchical Feature Learning</span>
                    
                    <span class="tag tag-keyword">Multi-scale Representation</span>
                    
                    <span class="tag tag-keyword">Computational Drug Discovery</span>
                    
                    <span class="tag tag-keyword">Sequence-based Prediction</span>
                    
                    <span class="tag tag-keyword">Bilinear Attention</span>
                    
                    <span class="tag tag-keyword">Drug Screening</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Abstract</h2>
                <p class="abstract">Accurate prediction of Drug-Target Affinity (DTA) is crucial for reducing
experimental costs and accelerating early screening in computational drug
discovery. While sequence-based deep learning methods avoid reliance on costly
3D structures, they still overlook simultaneous modeling of global sequence
semantic features and local topological structural features within drugs and
proteins, and represent drugs as flat sequences without atomic-level,
substructural-level, and molecular-level multi-scale features. We propose
HiF-DTA, a hierarchical network that adopts a dual-pathway strategy to extract
both global sequence semantic and local topological features from drug and
protein sequences, and models drugs multi-scale to learn atomic, substructural,
and molecular representations fused via a multi-scale bilinear attention
module. Experiments on Davis, KIBA, and Metz datasets show HiF-DTA outperforms
state-of-the-art baselines, with ablations confirming the importance of
global-local extraction and multi-scale fusion.</p>
            </section>

            
            <section class="paper-section">
                <h2>Comments</h2>
                <p>Accepted by International Conference on Bioinformatics and
  Biomedicine (BIBM 25)</p>
            </section>
            

            
        </article>
    </main>

    <footer class="container">
        <p><a href="../index.html">‚Üê Back to all papers</a></p>
    </footer>
</body>
</html>